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Abstract 29 
 30 
 Spexin, a neuropeptide discovered by bioinformatics approach, has been recently identified as a 31 
satiety factor in fish model.  However, the functional link between feeding and spexin expression as 32 
well as the signal transduction for spexin regulation is totally unknown.  Here we used goldfish as a 33 
model to examine the functional role of insulin as a postprandial signal for spexin regulation in bony 34 
fish.  In goldfish, feeding could elevate plasma levels of glucose, insulin and spexin with concurrent 35 
rises in insulin and spexin mRNA expression in the liver.  Similar elevation in spexin mRNA level was 36 
also observed in the liver and brain areas involved in appetite control in goldfish after intraperitoneal 37 
injection of glucose and insulin, respectively.  By parallel experiments with goldfish hepatocytes and 38 
brain cell culture, insulin signal induced by glucose was shown to exert dual role in spexin regulation, 39 
namely (i) acting as autocrine/paracrine signal to trigger spexin mRNA expression in the liver, and (ii) 40 
serving as endocrine signal to induce spexin gene expression in the brain.  Apparently, the peripheral 41 
(in the liver) and central actions of insulin (in the brain) on spexin gene expression were mediated by 42 
insulin receptor (to lesser extent by IGF-I receptor) coupled to MKK3/6/P38 
MAPK and PI3K/Akt/mTOR 43 
but not MEK1/2/ERK1/2 cascades.  Our findings indicate that an insulin component inducible by glucose 44 
is present in the liver of fish model and may serve as the postprandial signal linking food intake with 45 
spexin expression both in the central as well as at the hepatic level. 46 
 47 
(249 words)  48 
 49 
 50 
  51 
 3 
Introduction 52 
 53 
Spexin (SPX), the protein product of C12orf39 gene in human, is a novel peptide first identified 54 
by bioinformatics prior to its purification/functional studies (1, 2).  It is a 14-amino acid (a.a.) peptide 55 
with C-terminal α-amidation and its protein sequence is highly conserved from fish to mammals (3-5).  56 
In representative species, e.g., human (6), rat (7), mouse (2), and more recently in fish models (3-5, 8), 57 
SPX is widely expressed at tissue level suggesting that the peptide may have pleiotropic functions.  58 
This idea is consistent with the findings that SPX is involved/implicated in gastrointestinal motility (1, 59 
9), feeding and energy balance (4, 5), luteinizing hormone release (8), adrenocortical cell proliferation 60 
(10), nociception and cardiovascular/renal function (11) as well as O2 sensing in the carotid body (12).  61 
In human, low levels of serum SPX can be associated with insulin and lipid resistance (13), especially 62 
for type II diabetes (6) and both adult (14) and childhood obesity (15), which has aroused the interest 63 
in developing SPX-based analogs with pharmacological/therapeutic potential (16).  Recently, SPX has 64 
been shown to activate galanin type II and III receptors expressed in HEK293 cells (17), suggesting 65 
that the two receptors may act as the cognate receptors for SPX.  Despite the recent progress on SPX 66 
research, there is still a lack of information regarding the endocrine control of SPX expression and the 67 
signal transduction mechanism for SPX regulation is totally unknown. 68 
 69 
 To shed light on the comparative aspects of SPX in lower vertebrates, especially in fish species, 70 
we used goldfish as a model to establish the solution structure of fish SPX by NMR and confirm its 71 
expression at protein level within the brain by LC/MS/MS (4).  Using a combination of in vivo and in 72 
vitro approaches, SPX expression in brain areas involved in appetite control was shown to be elevated 73 
after food intake and SPX treatment via differential regulation of orexigenic and anorexigenic signals 74 
within these brain areas (by increasing CART, CCK & POMC with concurrent drop in NPY & AgRP 75 
expression) could inhibit feeding behavior and food consumption in goldfish (4), indicating that SPX 76 
can act a novel satiety factor in fish model.  Recently, the association of SPX expression with feeding 77 
has also been reported in fish species with commercial value, e.g., grouper (3) and Ya-fish (5), which 78 
raise the possibility of using SPX as a new target for manipulating/improving body growth and energy 79 
 4 
balance in cultured fish.  Although our study in goldfish has clearly demonstrated a central component 80 
of SPX expression in appetite control, the possibility for peripheral input of SPX was not examined.  81 
Furthermore, the functional link between food intake and SPX expression as well as the underlying 82 
mechanisms for SPX regulation are still unclear and remain to be investigated.  83 
 84 
 Since insulin is a major component of glucose homeostasis after feeding, and by itself, also acts as 85 
a satiety factor in mammals through modulation of orixegenic/anorexigenic signals (18), it raises the 86 
possibility that insulin may play a role in SPX regulation.  In this study, we sought to test the hypo-87 
thesis that glucose-induced insulin release/production caused by food intake might serve as a post-88 
prandial signal linking feeding with SPX expression in goldfish.  Whole animal experiments were 89 
conducted to investigate the effects of (i) food intake and (ii) intraperitoneal (IP) injection of glucose 90 
and insulin, respectively, on SPX expression in the liver and/or brain areas known to be involved in 91 
appetite control in goldfish.  In vitro studies were also performed in goldfish hepatocytes and brain 92 
cell culture to elucidate the receptor specificity as well as post-receptor signaling for SPX regulation 93 
by insulin using a combination of pharmacological approach and direct monitoring of activation status 94 
for signaling targets.  To our knowledge, our study represents the first report to (i) provide evidence for 95 
the dual role of insulin as both the endocrine as well as autocrine/paracrine signal triggered by feeding 96 
for SPX regulation, and (ii) establish the signal transduction mechanisms for SPX expression both in 97 
the central (the brain) as well as at the peripheral level (the liver). 98 
 99 
 100 
Materials and Methods 101 
 102 
Animal and test substances 103 
 104 
Goldfish (Carassius auratus) with 20-35 g body weight were purchased from local pet stores and 105 
maintained in well-aerated 650 L aquaria at 20 oC under 12D:12L photoperiod for more than 14 days 106 
prior to in vivo experiments/harvesting tissue for cell culture.  Since the fish used in our study were 107 
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sexually regressed and sexual dimorphism was not apparent, mixed sexes of goldfish were used for in 108 
vivo and in vitro experiments.  Drug treatment and tissue sampling were conducted as described by 109 
the protocols (CULATR#3890) approved by the Committee for Animal Use in Teaching and Research 110 
at the University of Hong Kong.  Human insulin and its antagonist S961 was obtained from Sigma (St. 111 
Louis, MO) while the inhibitors for insulin receptor (InsR) and/or IGF-I receptor (IGF1R), including 112 
picropodophyllin (PPP), 2-hydroxynaphthalenyl-methylphosphonic acid (HNMPA) and N-(5-chloro- 113 
2-methoxyphenyl)-N’-(2-methyl-4-quinolinyl)urea (PQ401), and blockers for target signaling kinases, 114 
including 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), 2-(2-amino-3-me-115 
thoxyphenyl)4H-1-benzopyranone (PD98059), 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo-116 
[3,4-c]pyridazin-3-amine (FR180204), (3R)-1-[2-oxo-2-[4-[4-(2-pyrimidinyl)phenyl]-1-piperazinyl]-117 
ethyl]-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide (SCH772984), 4-(4-fluorophen-118 
yl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole (PD169316), 4-[5-(4-fluorophenyl)-2-[4-(methyl-119 
sulfonyl)phenyl]-1H-imidazolyl]-pyridine (SB203580), wortmannin, 2-(4-morpholinyl)-8-phenyl-4H-120 
1-benxopyrin-4-one (LY294002), triciribine hydrate (API-2) and rapamycin, were acquired from Cal-121 
biochem (San Diego, CA).  These test substances were dissolved in PBS or DMSO, stored frozen in 122 
small aliquots at -80 oC and diluted with prewarmed culture medium to appropriate concentrations 10 123 
min prior to drug treatment. 124 
 125 
In vivo experiments for postprandial effect of feeding and glucose/insulin treatment 126 
 127 
 For in vivo experiments, goldfish (8-10 fish/group) were acclimated for ≥14 days to single housing 128 
in 25-liter tanks with a one-meal-per-day feeding schedule (with daily food supply at 10:00 AM).  To 129 
study the post-prandial effects of feeding, the fish were divided into two groups, one with regular 130 
supply of food pellets (~1% BW, as “fed group”) while the other without food provision (as “unfed 131 
group”), and the time for daily administration of fish feed was taken as time zero (0 hr) for reference.  132 
For in vivo treatment with glucose and insulin, IP injection of D-(+)-glucose or human insulin 133 
dissolved in fish physiological saline were conducted in goldfish under MS222 anesthesia 5 min prior 134 
to the regular feeding time but with no food provision after the fish recovered from the anesthesia 135 
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(which took 3-5 min for full recovery).  Sampling of blood and tissues was performed according to 136 
standard procedures (4) at the time points as indicated.  Circulating levels of glucose, insulin and SPX 137 
were measured using Glucose LiquiColor test (Stanbio Laboratory, Texas, USA), Fish Insulin ELISA 138 
kit (Cusabio Life Sci, Wuhan, China) and SPX Fluorescent EIA kit (Phoenix Peptides, Arizona, USA), 139 
respectively.  Total mRNA isolation, RT sample preparation and subsequent real-time PCR for target 140 
genes were carried out as described previously (19) with qPCR conditions listed in Supplemental 141 
Table (1).  Authenticity of PCR products were confirmed by melting curve analysis and parallel 142 
measurement of 18S RNA was used as the internal control.  To evaluate insulin expression at tissue 143 
level and InsR and IGF1R expression both in the hepatocytes and brain cell culture, RT-PCR was also 144 
performed for tissue expression profiling of insulin as well as detection of multiple isoforms of InsR/ 145 
IGF1R expressed in the respective cell culture with PCR protocols described in Supplemental Table 146 
(2).  In these studies, RT-PCR for β-actin was used as the quality control for RNA preparation. 147 
 148 
In vitro experiments with goldfish hepatocytes and brain cell culture 149 
 150 
 Goldfish hepatocytes (with viability ≥94%) were prepared by collagenase digestion method with 151 
minor modifications (19) and cultured in serum-free DMEM/F-12 medium (Invitrogen) at 0.8 × 106 152 
cells/ml/well in 24-well plates.  Goldfish brain cells (with viability ≥92%) were prepared from brain 153 
areas covering the telencephalon, optic tectum and hypothalamus by trypsin digestion as described 154 
previously (4) and cultured in 35-mm dishes at 3 × 106 cells/2 ml/dish with Neurobasal (Invitrogen) 155 
containing B27 supplement (1:50 dilution).  Cell cultures for the two target tissues were routinely 156 
prepared from tissues harvested from 6 goldfish and maintained at 28 oC under 5% CO2 and saturated 157 
humidity for 15 hr for carp hepatocytes (to avoid cell aggregation caused by prolonged culture) and 7 158 
days for brain cells (to allow for neuron recovery & glial cell attachment) prior to initiation of drug 159 
treatment.  After drug treatment, total RNA was extracted and subjected to real-time PCR for target 160 
gene measurement as described in the preceding section.  Real-time PCR for 18S RNA and β-actin 161 
were also conducted to serve as the internal control for hepatocyte and brain cell culture, respectively.  162 
For in vitro studies on SPX secretion, goldfish hepatocytes were cultured at 15 × 106 cells/2 ml/dish in 163 
 7 
60 mm dish and exposed to drug treatment in the presence of 1 × dilution of the Complete ™ protease 164 
inhibitor cocktail (Roche).  After that, culture medium harvested was concentrated using C18 Sep-Pak 165 
chromatography (Waters) and used for SPX measurement with SPX Fluorescent EIA kit. 166 
 167 
Western blot of kinase activation induced by insulin treatment 168 
 169 
To examine the post-receptor signaling for insulin-induced SPX gene expression, Western blot 170 
was performed in cell lysate prepared from goldfish hepatocytes or brain cell culture after insulin 171 
treatment as described previously (20) using antibodies specific for the phosphorylated form (“P-”) 172 
and total protein (“T-”) of MEK1/2 (1:1,000), ERK1/2 (1:5,000), MKK3/6 (1: 2,000), P38
 MAPK (1: 1,000), 173 
PI3K (1:2,000) and Akt (1:1,500), respectively (see Antibody Table for the details of these antibodies 174 
and their respective suppliers).  In these studies, parallel blotting of β-actin was used as the loading 175 
control.  Quantitation of the results of Western blot was performed by densitometric scanning using 176 
ImageJ (https://imagej.nih.gov/ij/) and the data was transformed as a ratio of the phosphorylated form 177 
over the total protein of the respective targets. 178 
 179 
Data transformation and statistics 180 
 181 
For real-time PCR, standard curves with dynamic range of  ≥ 105 and correlation coefficient of  ≥ 182 
0.95 were constructed for data calibration with serial dilutions of plasmids carrying the ORF of target 183 
genes.  The raw data of mRNA expression for in vivo experiments (in terms of femtomole transcript 184 
detected/assay tube) were normalized against 18S RNA expression detected in the same sample and 185 
transformed as a percentage of the mean value for target gene expression in control group at time zero 186 
(i.e., as “%Ctrl” of the reference group at 0 hr).  For in vitro experiments with cell culture, the raw data 187 
of mRNA expression were measured in terms of femtomole transcript/106 cells/well.  These data were 188 
normalized against β-actin mRNA in the case of brain cell culture and transformed as a percentage of 189 
the control group without drug treatment (as “%Ctrl”).  Since 18S RNA levels (the internal control for 190 
hepatocytes) did not exhibit notable changes in our in vitro experiments, the raw data for target gene 191 
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expression in goldfish hepatocytes were simply transformed as a percentage of the mean value in the 192 
control (as “%Ctrl”) or fold increase versus the control group (as “fold induction”) without 18S RNA 193 
normalization .  Data presented for plasma levels of glucose and insulin as well as for real-time PCR 194 
of target gene expression are expressed as mean ± SEM (N = 8-10 for in vivo experiments & 4-8 for 195 
in vitro experiments).  Data for time-course studies were analyzed with two-way ANOVA followed by 196 
Bonferroni post-hoc test with time and treatment as the two variables for statistical analysis.  The data 197 
for dose-dependence/drug treatment to elucidate post-receptor signaling were analyzed with one-way 198 
ANOVA followed by Newman-Keuls test.  Differences between groups were considered as significant 199 
at P < 0.05. 200 
 201 
 202 
Results 203 
 204 
Functional role of insulin in SPX regulation in vivo  205 
 206 
 In goldfish entrained with one-meal-per-day feeding schedule, significant rises of glucose, insulin 207 
and SPX levels were observed in the plasma with peaks at 1 hr after initiation of feeding (at time zero) 208 
when compared to the time-matched unfed groups (Fig.1A-C).  In the unfed groups, however, plasma 209 
levels of glucose, insulin and SPX were reduced in a time-dependent manner with respect to their pre-210 
prandial basal.  Pearson analysis of the data for plasma samples also revealed that positive correlation 211 
could be noted between plasma levels of insulin and glucose (Fig.1D), SPX and glucose (Fig.1E) and 212 
SPX and insulin (Fig. 1F), respectively.  In goldfish, as revealed by RT-PCR, insulin was found to be 213 
widely expressed in different tissues (e.g., the brain, gills, heart, gut, spleen, kidney, liver, muscle and 214 
gonads) and brain areas (e.g., the olfactory bulb, telencephalon, optic tectum, hypothalamus, pituitary, 215 
cerebellum, medulla oblongata and spinal cord), with the highest level of insulin signal detected in the 216 
liver (Fig.2A).  In the same feeding experiment, besides the rises in plasma insulin and SPX, rapid 217 
elevation of insulin (Fig.2B) and SPX mRNA levels (Fig.2C) could also be observed in the liver with 218 
peaks at 1 hr after food provision, suggesting that the liver may serve as a source of insulin and SPX 219 
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in circulation. 220 
 221 
 In parallel experiment, IP injection of goldfish with D-(+)-glucose could elevate plasma levels of 222 
glucose (Fig.3A) with concurrent rises of insulin and SPX mRNA expression in the liver (Fig.3B & 223 
3C).  The treatment, however, did not induce notable changes in hepatic expression of IGF-I and IGF-224 
II transcripts (Supplemental Fig.1A).  After IP injection of D-(+)-glucose, rapid rises of SPX mRNA 225 
levels were also observed within the first 30 min in brain areas involved in feeding control, including 226 
the hypothalamus (Fig.3D), telencephalon (Fig.3E) and optic tectum (Fig.3F).  To examine the role of 227 
insulin in SPX regulation, IP injection of human insulin was also performed in goldfish.  Insulin of 228 
human origin was used because (i) fish insulin with bioactivity is not commercially available, and (ii) 229 
human insulin is highly homologous to goldfish counterpart (84% in B-domain & 78% in A-domain, 230 
which form the mature peptide of insulin).  In our study, IP injection with human insulin was shown to 231 
reduce plasma levels of glucose in goldfish (Fig.4A), indicating that human insulin is fully functional 232 
in fish model.  Meanwhile, plasma levels of SPX (Fig.4B) as well as SPX mRNA expression in the 233 
liver (Fig.4C) and brain areas including the hypothalamus (Fig.4D), telencephalon (Fig.4E) and optic 234 
tectum (Fig.4F) were found to be elevated shortly after insulin treatment.  To evaluate the functional 235 
role of insulin in glucose-induced SPX release and gene expression, IP injection of D-(+)-glucose was 236 
tested with co-treatment of the insulin antagonist S961.  Similar to our time-course study, IP injection 237 
of glucose consistently elevated plasma glucose (Fig.5A) and SPX levels (Fig.5B) with parallel rises 238 
in SPX mRNA expression in the liver (Fig.5C) and brain areas including the hypothalamus (Fig.5D), 239 
telencephalon (Fig.5E) and optic tectum (Fig.5F).  These stimulatory effects, however, were found to 240 
be suppressed/totally abolished by S961 co-treatment. 241 
 242 
SPX regulation by insulin in goldfish hepatocytes 243 
 244 
 To shed light on SPX regulation by insulin at the hepatic level, primary culture of hepatocytes was 245 
prepared from goldfish (Supplemental Fig.2A) and validation based on growth hormone-induced IGF-246 
I mRNA expression also confirmed that the cell culture was responsive to hormone stimulation under 247 
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serum-free condition (Supplemental Fig.2B), which is highly desirable for subsequent investigation of 248 
insulin action.  As revealed by RT-PCR, expression of the receptors for insulin (including InsR1 and 249 
InsR2) and IGF-I (only for IGF1R2 but not IGF1R1) could be detected in the goldfish liver as well as 250 
hepatocyte culture (Fig.6A), implying that the hepatocytes can act as the regulatory target for the two 251 
endocrine factors.  Under serum-free condition, static incubation of goldfish hepatocytes with D-(+)-252 
glucose was found to elevate insulin (Fig.6B) and SPX mRNA levels (Fig.6C) in a dose-related manner 253 
without notable changes in IGF-I and -II gene expression (Supplemental Fig.1B).  Parallel studies with 254 
insulin treatment also triggered a time- (Fig.6D) and dose-dependent elevation (Fig.6F) in SPX mRNA 255 
expression but similar treatment with glucagon was found to have no effects (Fig.6E).  256 
 257 
 In mammals, insulin and IGF-I are known to cross-react at receptor level (21).  In our study, the 258 
receptor specificity for SPX regulation by insulin was also examined at the hepatic level.  In goldfish 259 
hepatocytes, insulin induction was effective in triggering rapid phosphorylation of InsR (Fig.7A) and 260 
IGF1R (Fig.7B) with peaks at 15 min after drug treatment.  At hepatocyte level, insulin-induced SPX 261 
mRNA expression was significantly suppressed by the InsR inhibitor HNMPA (by 83%) but similar 262 
treatment with the IGF1R blocker PPP could only induce a mild/marginal inhibition (by 16%) for the 263 
corresponding response (Fig.7C).  However, the stimulatory effect of insulin could be totally abolished 264 
by PQ401, an inhibitor known to block InsR and IGR1R activation at the dose examined.  In separate 265 
studies, co-treatment with the insulin antagonist S961 or InsR inhibitor HNMPA was also effective in 266 
blocking the stimulatory effect of D-(+)-glucose on SPX gene expression in goldfish hepatocytes (Fig. 267 
7D), and again, a marginal inhibition could be noted with parallel inhibition using the IGF1R blocker 268 
PPP (data not shown).  To shed light on the effect of InsR activation on SPX secretion at the hepatic 269 
level, a high-density culture system supplemented with Complete ™ protease inhibitor cocktail was 270 
established for goldfish hepatocytes.  Based on our validation, the protease inhibitors did not alter the 271 
viability nor overall morphology of our cell culture (Supplemental Fig.3A) and with no notable effect 272 
on insulin, SPX and -actin gene expression (Data not shown).  Using this high-density cell culture, a 273 
2-hr treatment with D-(+)-glucose (Supplemental Fig.3B) or insulin (Supplemental Fig.3C) was found 274 
to elevate SPX release and the stimulatory effect by D-(+)-glucose could be negated by co-treatment 275 
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with the InsR inhibitor HNMPA (Supplemental Fig.3D). 276 
 277 
 Given that InsR is known to be functionally coupled with MAPK and PI3/Akt pathways (22), the 278 
possible involvement of these post-receptor signaling cascades in SPX expression induced by insulin 279 
was also examined.  Similar to the rapid phosphorylation of InsR, insulin treatment was effective in 280 
triggering protein phosphorylation of MEK1/2, ERK1/2, MKK3/6, P38 
MAPK, PI3K and Akt in goldfish 281 
hepatocytes with peaks at 15 min after drug administration (Fig.8A-C).  In parallel studies with insulin 282 
treatment in the presence of inhibitors for various signaling targets, SPX mRNA expression caused by 283 
insulin stimulation was not affected by the MEK1/2 inhibitor U1026 or PD98059 (Fig.9A) or ERK1/2 284 
blocker FR180204 or SCH772984 (Fig.9B).  However, the SPX responses triggered by insulin could 285 
be reduced by simultaneous incubation with the P38 
MAPK inhibitor PD169316 or SB203580 (Fig.9C), 286 
PI3K inactivator LY294002 or wortmannin (Fig.9D), Akt blocker API-2 or mTOR inhibitor rapamycin 287 
(Fig.9E).  Furthermore, insulin-induced SPX gene expression could be totally abolished by exposing 288 
goldfish hepatocytes to the P38 
MAPK inhibitor PD169316 and PI3K inactivator LY294002 at the same 289 
time (Fig.9F). 290 
 291 
SPX regulation by insulin in goldfish brain cells  292 
 293 
 Since insulin treatment, similar to glucose challenge, could elevate SPX gene expression in vivo 294 
in the telencephalon, hypothalamus and optic tectum of the goldfish, goldfish brain cell culture was 295 
prepared from these brain areas (4) and used as a cell model to study the central actions of insulin on 296 
SPX regulation.  In this cell culture, B27 supplement (with 4 mg/L insulin, Invitrogen) was used as a 297 
serum substitute to maintain a serum-free culture condition.  To examine the effect of removing insulin 298 
intrinsic to the cell culture system, the serum substitute was replaced with an insulin-free preparation 299 
of B27 (Invitrogen).  In this case, basal expression of SPX mRNA was reduced to a low level with no 300 
effect on β-actin gene expression (Fig.10A).  In brain cells cultured with normal preparation of B27, 301 
insulin treatment was found to have the opposite effect and elevate SPX mRNA levels in a time- (Fig. 302 
10B) and dose-related fashion (Fig.10C) with peak responses observed at 12 hr after initiation of drug 303 
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treatment. 304 
 305 
 As revealed by RT-PCR, transcript signals of the receptors for insulin (including InsR1 and InsR2) 306 
and IGF-I (including IGF1R1 and IGF1R2) could be detected in the brain as well as brain cell culture 307 
prepared from the goldfish (Fig.10D), implying that the central nervous system (CNS) is a regulatory 308 
target for insulin and IGF-I in fish model.  In goldfish brain cells, SPX mRNA expression induced by 309 
insulin could be totally negated by the InsR inhibitor HNMPA while the parallel blockade with IGF1R 310 
inactivator PPP could only yield a partial inhibition (~50%, Fig.10E).  Regarding the post-receptor 311 
signaling for insulin induction, similar to the results in hepatocytes, insulin was effective in triggering 312 
rapid phosphorylation of MEK1/2, ERK1/2, MKK3/6, P38 
MAPK, PI3K and Akt in brain cell culture (Fig. 313 
11A-C).  Parallel experiments also revealed that SPX mRNA expression induced by insulin was not 314 
sensitive to the blockade by the MEK1/2 inhibitor PD98059 or ERK1/2 blocker FR180204 (Fig.12A).  315 
In contrast, the SPX responses could be obliterated by co-treatment of insulin with the P38 
MAPK 316 
inhibitor PD169316, PI3K inactivator LY294002, Akt blocker API-2 and mTOR inhibitor rapamycin, 317 
respectively (Fig.12A & B). 318 
 319 
 As shown in our tissue profiling for insulin expression (Fig.2A), insulin signal was also located in 320 
the brain of goldfish, especially in the hypothalamus, telencephalon and optic tectum.  These findings 321 
raise the possibility that insulin produced locally within the brain may play a role in SPX regulation 322 
by glucose in the CNS.  In our in vivo experiment, however, IP injection of D-(+)-glucose consistently 323 
increased plasma insulin and insulin mRNA level in the liver (positive control of the study) but with 324 
no effect on insulin gene expression in hypothalamus, telencephalon and optic tectum (Supplemental 325 
Fig.4A).  In parallel study with goldfish brain cell culture, similarly, treatment with D-(+)-glucose up 326 
to 24 hr was found to be ineffective in altering basal levels of insulin and SPX mRNA expression 327 
(Supplemental Fig.4B).  These results suggest that insulin expression within the brain of goldfish is 328 
not responsive to glucose changes in circulation.  Probably, insulin from circulation rather than blood 329 
glucose represents the major signal for SPX regulation within the CNS.  330 
 13 
Discussion 331 
 332 
 SPX, a novel peptide identified by bioinformatics (1), has recently emerged as a regulatory factor 333 
with pleiotropic functions (see introduction for details).  Since its association with energy balance and 334 
obesity has been reported in human and animal models (14) and plasma levels of SPX can be used as 335 
a marker for childhood obesity (15) and type II diabetes (6), the studies on SPX have aroused a lot of 336 
interest in the field.  The research on SPX has become even more interesting with our recent study in 337 
goldfish revealing that central expression of SPX induced by food intake could act as a satiety signal 338 
to inhibit feeding behavior in fish model via modulation of orexigenic/anorexigenic factors expressed 339 
in brain areas involved in appetite control (4).  Given that insulin, a key component of glucose homeo-340 
stasis, is responsive to feeding, and by itself, also acts as an anorexigenic factor for signal integration 341 
of satiation and body adiposity (23), we postulate that it may be involved in SPX expression in fish 342 
model.  In our feeding experiment, food intake could elevate plasma levels of glucose, insulin and 343 
SPX in goldfish with concurrent increase in insulin and SPX gene expression in the liver.  Our results 344 
for the first time demonstrated that, besides the central expression of SPX, feeding could also induce a 345 
peripheral component of SPX, presumably through elevation of SPX production in the liver followed 346 
by SPX release into systemic circulation.  Since (i) glucose-induced insulin release via ATP-sensitive 347 
K+ channels (24) and sweet taste-sensing receptors (25) coupled to mitochondrial signal amplification 348 
(26) is well documented, and (ii) a positive correlation could be noted for plasma levels of glucose, 349 
insulin and SPX in our feeding experiment, it raises the possibility that glucose-induced insulin signals 350 
caused by feeding might play a role in SPX regulation.  This idea is supported by our findings that (i) 351 
IP injection of glucose in goldfish could elevate plasma insulin and hepatic expression of insulin and 352 
SPX mRNA levels, and (ii) parallel treatment with insulin not only could induce SPX gene expression 353 
in the liver but also increase plasma levels of SPX.  In both cases, SPX mRNA levels in brain areas 354 
involved in appetite control (i.e., hypothalamus, telencephalon & optic tectum) were also increased by 355 
glucose and insulin induction.  Given that glucose-induced SPX secretion and SPX gene expression in 356 
the brain and liver were also sensitive to in vivo blockade by the insulin antagonist S961, it would be 357 
logical to conclude that the insulin signal caused by postprandial rise in blood glucose can contribute 358 
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to the SPX responses within the CNS and at the hepatic level in fish model. 359 
 360 
 In bony fish, endocrine pancreas exists as Brockman bodies scattering in the gut mesentery, e.g., 361 
in tilapia (27) and wolfish (28), while exocrine pancreas (mainly in the form of glandular acinus) can 362 
also spread into the liver leading to the formation of hepatopancreas in some species (29).  Although 363 
hepatopancreas has been reported in the goldfish (30), the presence of an endocrine component of the 364 
pancreas has not been documented at the hepatic level.  In our study, distinct structure for Brockman 365 
bodies could not be identified in the goldfish but the highest level of insulin expression was located in 366 
the liver.  Furthermore, our experiments with IP injection of glucose in vivo and glucose treatment in 367 
hepatocytes in vitro have clearly shown that insulin signals not only could be detected at hepatic level 368 
but also inducible by glucose with parallel increase in SPX gene expression.  In goldfish hepatocytes, 369 
glucose and insulin induction were both effective in elevating SPX mRNA levels and glucose-induced 370 
SPX secretion and gene expression could be negated by insulin antagonist S961 and/or InsR inhibitor 371 
HNMPA.  These findings, taken together, suggest that (i) an insulin component responsive to glucose 372 
induction is present in the goldfish liver, and (ii) local production of insulin induced by glucose may 373 
act in an autocrine/paracrine manner to trigger SPX release/expression at hepatic level.  In mammals, 374 
autocrine/paracrine actions of insulin have also been reported in the brain and involved in cognitive 375 
functions related to memory, learning and food anticipation (31).  However, the local action of insulin 376 
produced at hepatic level has not been reported.  Since glucagon did not alter SPX gene expression in 377 
our hepatocyte culture, it would be logical to assume that local production of glucose (e.g., by glyco-378 
genolysis/gluconeogenesis) may not have a major role in SPX regulation.  Judging from the fact that 379 
the liver represents the largest organ in the body and serves as a major target for insulin, especially for 380 
glucose (32) and lipid homeostasis (33), the hepatopancreas in goldfish with an inducible component 381 
of insulin may also act as a source of insulin for both local actions as well as endocrine functions via 382 
blood circulation.  Although Brockman’s bodies could not be identified in goldfish, we do not exclude 383 
the possibility that postprandial rise in blood glucose could also induce insulin release from goldfish 384 
pancreas which may also contribute to SPX regulation in the liver as well as in brain areas involved in 385 
appetite control. 386 
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 387 
 Of note, glucose treatment, both in vivo and in vitro, did not alter hepatic expression of IGF-I/-II 388 
mRNA levels in our studies, the possible involvement of local production of IGFs for SPX regulation 389 
is rather unlikely.  In mammals, insulin is known to cross-react with IGF1R (21) and InsR and IGF1R 390 
are functionally coupled with MAPK and PI3K/Akt pathways (34).  In some tissues (e.g., placenta), 391 
InsR and IGF1R can also form hybrid receptors (35) with higher affinity for IGF-I (36).  In bony fish, 392 
isoforms of InsR (37) and IGF1R (38) have been cloned and believed to be the result of whole genome 393 
duplication occurred during the evolution of teleost lineage (39).  In goldfish hepatocytes, two forms 394 
of InsR (InsR1 & InsR2) and one form of IGF1R (IGF1R2) could be identified by RT-PCR and insulin 395 
exposure was found to induce rapid phosphorylation of InsR and IGF1R, suggesting that the receptors 396 
for insulin and IGF-I may play a role in mediating insulin functions at the hepatic level.  Given that (i) 397 
the InsR inhibitor HNMPA was notably more effective (83% blockade) than the IGF1R inhibitor PPP 398 
(16% blockade) in attenuating insulin-induced SPX mRNA expression in goldfish hepatocytes, and (ii) 399 
the SPX responses caused by insulin was totally abolished by PQ401, an inhibitor known to inactivate 400 
both InsR and IGF1R at the dose tested, it is conceivable that the two receptors are both involved in 401 
SPX regulation at hepatic level with InsR as the dominant form mediating insulin action.  Regarding 402 
the post-receptor signaling mechanisms for SPX regulation, insulin was capable of triggering MEK1/2, 403 
ERK1/2, MKK3/6, P38 
MAPK, PI3K and Akt phosphorylation in goldfish hepatocytes.  These results are 404 
comparable with the recent report on InsR signaling in trout adipocytes (40) and consistent with the 405 
idea that InsR signaling via MAPK and PI3K/Akt cascades is well conserved in vertebrate evolution 406 
(41).  In goldfish hepatocytes, however, insulin-induced SPX mRNA expression was not affected by 407 
the inhibitors for MEK1/2 (U0126 & PD98059) or ERK1/2 (FR18024 & SCH772984), but attenuated 408 
by the inhibitors for P38 
MAPK (PD169316 & SB20380), PI3K (LY294002 & Wormannin), Akt (API-2) 409 
and mTOR (Rapamycin), respectively.  Besides, the SPX responses caused by insulin could be totally 410 
negated by co-treatment with the inhibitors for P38 
MAPK
 (PD169316) and PI3K (LY294002), suggesting 411 
that the MKK3/6/P38 
MAPK and PI3K/Akt/mTOR but not MEK1/2/ERK1/2 cascades are involved in SPX 412 
gene expression induced by insulin at the hepatic level in fish model. 413 
 414 
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 As mentioned in the preceding section, insulin signals induced by glucose could also trigger SPX 415 
gene expression in brain areas involved in appetite control, which might initiate the satiation response 416 
after feeding in goldfish via differential regulation of orexigenic/anorexigenic signals within the CNS.  417 
This idea is comparable to the model in mammals with central regulation of energy balance and body 418 
weight via modulation of feeding regulators (e.g., NPY & POMC) within the hypothalamus by satiety 419 
signals (e.g., leptin) (42).  In our study, the effect of insulin on central expression of SPX was further 420 
substantiated by in vitro experiments with goldfish brain cells, in which (i) removing insulin from the 421 
cell culture system (using insulin-free B27) could suppress basal level of SPX mRNA, and (ii) insulin 422 
treatment, in contrast, could up-regulate SPX gene expression in a time- and dose-related manner.  Our 423 
findings are also in agreement with the previous reports (e.g., in rodents) on (i) insulin uptake into the 424 
CNS by transcytosis across choroid plexus via InsR coupled to LRP2/megalin (43) and (ii) the role of 425 
insulin as an anorexigenic factor via its central actions in modulating NPY, AgRP, POMC and MCR4 426 
expression (44).  Apparently, SPX can serve as a novel component for the central actions of insulin on 427 
appetite control.  Since insulin expression within the brain in goldfish was not responsive to glucose 428 
in vivo and in vitro, it is likely that insulin from circulation rather than blood glucose represents the 429 
key signal triggering SPX expression within the CNS in fish model.  Regarding the receptor specificity 430 
for insulin’s action within the CNS, the results of RT-PCR revealed that multiple isoforms of InsR 431 
(InsR1 & InsR2) and IGF1R (IGF1R1 & IGF1R2) could be detected in the whole brain as well as brain 432 
cell culture prepared from the goldfish.  Similar to goldfish hepatocytes, insulin-induced SPX mRNA 433 
expression in brain cells was found to be more sensitive to the blockade by the InsR inhibitor HNMPA 434 
(~100%) compared to similar treatment with the IGF1R inhibitor PPP (~50% blockade).  These results 435 
again suggest that the central effect of insulin on SPX expression is mediated mainly by InsR and to a 436 
lower extent by IGF1R.  Unlike the brain, IGF1R1 was undetectable in goldfish liver/hepatocytes and 437 
IGF1R2 was the only IGF1R identified at the hepatic level, implying that different isoforms of IGF1R 438 
are expressed in a tissue-specific manner.  Whether it can also contribute to the tissue-specific actions 439 
of IGFs as recently reported for insulin/IGF-I signaling in body metabolism and aging in rodents (45) 440 
is unclear and remains to be investigated.  Although insulin was effective in triggering protein phos-441 
phorylation of MEK1/2, ERK1/2, MKK3/6, P38 
MAPK, PI3K and Akt in goldfish brain cells, SPX mRNA 442 
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expression induced by insulin in the cell culture was not sensitive to the blockade of MEK1/2 (e.g., by 443 
PD98059) and ERK1/2 (e.g., by FR180204) but could be totally abolished by inhibiting P38 
MAPK (e.g., 444 
by PD169316), PI3K (e.g., by LY294002), Akt (e.g., by API-2) and mTOR (e.g., by Rapamycin), 445 
respectively.  These findings as a whole confirm that, similar to the case of goldfish hepatocytes, the 446 
central effect of insulin on SPX regulation is also mediated by MKK3/6/P38 
MAPK and PI3K/Akt/mTOR 447 
but not MEK1/2/ERK1/2 cascades. 448 
 449 
 In summary, using goldfish as animal model, we have demonstrated for the first time that insulin 450 
signals induced by postprandial rise in blood glucose could serve as the functional link between food 451 
intake and SPX expression both in the central (i.e., within CNS) and periphery (i.e., in the liver).  In 452 
our study, we also have the novel finding that the liver in goldfish represents a major site of insulin 453 
expression, which is also inducible by changes in glucose levels.  In our working model (Fig.13), food 454 
intake in goldfish can induce insulin expression in the liver via elevation in blood glucose (probably 455 
with parallel rise in insulin signal from the pancreatic).  Local production of insulin acts in an auto-456 
crine/paracrine manner to increase SPX expression at the hepatic level via InsR (to a lesser extent via 457 
IGF1R) coupled to the MKK3/6/P38 
MAPK and PI3K/Akt pathways.  Hepatic output of SPX also elevates 458 
SPX level in circulation and constitutes a peripheral SPX signal acting on the CNS.  Meanwhile, 459 
insulin released from the liver (together with pancreatic insulin) can elevate insulin level in blood and 460 
serve as an endocrine signal to induce SPX expression in brain areas involved in feeding behavior.  461 
Apparently, the central effect of insulin on SPX expression is also mediated through InsR coupled with 462 
MKK3/6/P38 
MAPK and PI3K/Akt signaling.  Since our previous study with ICV injection of SPX in 463 
goldfish has confirmed that (i) SPX by acting centrally could inhibit feeding behavior and food intake, 464 
and (ii) these inhibitory effects were mediated by SPX inhibition of NPY and AgRP with concurrent 465 
stimulation of CART, CCK and POMC expression in brain areas involved in appetite control (4), local 466 
production of SPX within the CNS together with the SPX input from the periphery induced by insulin 467 
presumably can inhibit feeding behavior in goldfish via differential actions on orexigenic/anorexigenic 468 
signals within the feeding circuitry in the brain.  Our study, as a whole, has provided new insights on 469 
the mechanisms and signal transduction for the role of SPX as a satiety factor in fish model.  Of note, 470 
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plasma SPX is closely associated with glucose homeostasis (e.g., in diabetic patient) (6) and fatty acid 471 
uptake/body adiposity (e.g., in obese mouse) (14).  The role of circulating SPX induced by feeding in 472 
energy balance and glucose/lipid metabolism for sure will be an interesting topic for further perusal.  473 
Recently, type II and III galanin receptors have been proposed to be the cognate receptor for SPX, and 474 
interestingly, type III galanin receptor could not be found in the genome of fish species, e.g., zebrafish 475 
(17), research is now underway in our laboratory to study the receptor specificity as well as the post-476 
receptor signaling mechanisms for SPX-induced satiation and regulation of orexigenic/anorexigenic 477 
factors expressed within the brain in goldfish. 478 
 479 
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Legends 613 
 614 
Fig.1    Effects of food intake on plasma levels of glucose, insulin and SPX in goldfish.  Goldfish 615 
entrained with a one-meal-per-day feeding schedule (with 8 fish/group) was provided with fish feed at 616 
10:00 AM (taken as 0 hr as marked by the arrow) in treatment group (as “fed” group) but without food 617 
provision in the control group (as “unfed” group).  Blood samples were harvested from caudal 618 
vasculature in individual fish at the time points as indicated and subjected to respective assays for the 619 
measurement of plasma glucose (A), insulin (B) and SPX (C).  Pearson analysis was also performed 620 
with the plasma data for glucose and insulin (D), glucose and SPX (E), and insulin and SPX (F), 621 
respectively.  Except for Pearson analysis (with raw data), data presented are expressed as mean ± 622 
SEM (N = 8) and groups denoted by different letters represent a significant difference at P < 0.05. 623 
  624 
Fig.2    Tissue expression profile of insulin in goldfish and postprandial changes in hepatic expression 625 
of insulin and SPX.  (A) RT-PCR of insulin expression in selected tissues and brain areas in goldfish.  626 
Total RNA was isolated from the tissue/brain area as indicated and subjected to RT-PCR with primers 627 
specific for goldfish insulin.  The authenticity of PCR product was confirmed by PCR Southern using 628 
a DIG-labeled probe for goldfish insulin and RT-PCR for β-actin was used as internal control.  Effects 629 
of food intake on (B) insulin and (C) SPX gene expression in the liver of goldfish.  In the same study 630 
described in Fig.1, total RNA was isolated from the liver at the respective time points in the “fed” and 631 
“unfed” groups and subjected to real-time PCR for insulin and SPX mRNA measurement.  Parallel 632 
measurement of 18S RNA was performed to serve as the internal control for data normalization.  Data 633 
presented for the temporal changes of insulin and SPX mRNA levels are expressed as mean ± SEM 634 
(N = 8) and groups denoted by different letters represent a significant difference at P < 0.05. 635 
 636 
Fig.3    In vivo treatment with glucose on central and peripheral expression of SPX in goldfish.  Fish 637 
entrained with one-meal-per-day feeding schedule (8 fish/group) were IP injected with D-(+)-glucose 638 
(1.5 mg/g BW) at 10:00 AM (taken as 0 hr) without food provision.  Parallel injection with physio-639 
logical saline was used as the control.  At the time points as indicated, blood samples were collected 640 
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for measurement of plasma glucose (A).  For peripheral tissue, total RNA was isolated from the liver 641 
at the respective time points for real-time PCR of (B) insulin and (C) SPX mRNA expressed at the 642 
hepatic level.  For central expression of SPX, RNA samples were isolated from (D) the hypothalamus, 643 
(E) telencephalon and (F) optic tectum respectively and used for SPX mRNA measurement in selected 644 
brain areas.  In this study, parallel measurement of 18S RNA was used as the internal control.  Data 645 
presented are expressed as mean ± SEM (N = 8) and groups denoted by different letters represent a 646 
significant difference at P < 0.05. 647 
 648 
Fig.4    In vivo treatment with insulin on central and peripheral expression of SPX in goldfish.  Fish 649 
entrained with one-meal-per-day feeding schedule (8 fish/group) were IP injected with insulin (4 USP 650 
units/g BW) at 10:00 AM (taken as 0 hr) without food provision.  Parallel injection with physiological 651 
saline was used as the control.  At the time points as indicated, blood samples were collected for 652 
plasma glucose (A) and SPX measurement (B).  Meanwhile, total RNA was isolated from the liver 653 
(C) and brain areas including the hypothalamus (D), telencephalon (E) and optic tectum (F) for real-654 
time PCR of SPX mRNA measurement.  Parallel measurement of 18S RNA was also conducted to 655 
serve as the internal control.  Data presented are expressed as mean ± SEM (N = 8) and groups 656 
denoted by different letters represent a significant difference at P < 0.05. 657 
 658 
Fig.5    In vivo blockade by insulin antagonist on glucose-induced central and peripheral expression of 659 
SPX in goldfish.  Goldfish entrained with one-meal-per-day feeding schedule (10 fish/group) were IP 660 
injected with D-(+)-glucose (1.5 mg/g BW) at 10:00 AM (without food provision) with or without co-661 
injection of the insulin antagonist S961 (30 nmole/kg BW).  Parallel injection with saline was used as 662 
the control.  Blood sampling and tissue collection were conducted 30 min after drug treatment.  663 
Plasma samples prepared were used for measurement of plasma glucose (A) and SPX levels (B).  For 664 
peripheral expression of SPX, total RNA was isolated from the liver for real-time PCR of SPX mRNA 665 
expression at the hepatic level (C).  For central expression of SPX, RNA samples were isolated from 666 
the hypothalamus (D), telencephalon (E) and optic tectum (F), respectively, and used for SPX mRNA 667 
measurement in selected brain areas.  In this study, parallel measurement of 18S RNA was used as the 668 
 26 
internal control.  Data presented are expressed as mean ± SEM (N = 10) and groups denoted by 669 
different letters represent a significant difference at P < 0.05. 670 
 671 
Fig.6    Functional role of glucose and insulin on SPX gene expression in goldfish hepatocytes.  InsR 672 
and IGF1R expression at the hepatic level:  (A) RT-PCR of different isoforms of InsR (InsR1 & InsR2) 673 
and IGF1R (IGF1R1 & IGF1R2) expressed in the liver and hepatocyte culture prepared from goldfish 674 
using primers for the respective gene targets.  RT-PCR for InsR and IGF1R expressed in muscle was 675 
used as positive control and parallel PCR for β-actin was used as internal control.  Regulation of SPX 676 
mRNA expression in primary culture of goldfish hepatocytes:  Dose-dependence of glucose treatment 677 
on (B) insulin and (C) SPX mRNA expression in goldfish hepatocytes.  Hepatocytes were treated for 678 
48 hr with increasing concentrations of D-(+)-glucose and subjected to RNA isolation and real-time 679 
PCR for insulin and SPX mRNA measurement.  Time course of (D) insulin and (E) glucagon 680 
treatment on SPX mRNA expression.  Goldfish hepatocytes were incubated with insulin (100 nM) or 681 
glucagon (100 nM) for the duration as indicated.  Dose-dependence of insulin (F) on SPX mRNA 682 
expression was also examined in the cell culture with duration of drug treatment fixed at 48 hr.  Data 683 
presented are expressed as mean ± SEM (N = 8) and groups denoted by different letters represent a 684 
significant difference at P < 0.05. 685 
 686 
Fig.7    Receptor specificity of SPX regulation by insulin in goldfish hepatocytes.  Effects of insulin 687 
on (A) InsR and (B) IGF1R phosphorylation in goldfish hepatocytes.  Cell culture was incubated with 688 
insulin (10 nM) for the duration as indicated.  After that, cell lysate prepared was used for Western blot 689 
with antibodies specific for phosphorylated form (“P-”) and total protein (“T-”) of InsR and IGF1R, 690 
respectively.  In this experiment, Western blot for β-actin was used as the loading control.  The results 691 
of Western blot were shown in the panels on the left while the quantitative data expressed as the ratio 692 
of the signal intensity (registered by densitometric scanning using ImageJ) of the P-form over the T-693 
form of target protein were presented in the right panels.  (C) Effects of blocking InsR and IGF1R on 694 
insulin-induced SPX mRNA expression.  Goldfish hepatocytes were exposed to insulin (10 nM) for 48 695 
hr with/without the IGF1R inhibitor PPP (10 μM), InsR inhibitor HNMPA (10 μM) or non-selective 696 
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InsR/IGF1R inhibitor PQ401 (50 μM).  (D) Insulin blockade on glucose-induced SPX gene expression 697 
at the hepatic level.  Hepatocytes were exposed to D-(+)-glucose (6 g/L) for 48 hr with co-treatment 698 
of the insulin antagonist S961 (500 nM) or InsR inhibitor HNMPA (10 μM).  After drug treatment, 699 
total RNA was isolated and subjected to real-time PCR for SPX mRNA measurement.  Data presented 700 
are expressed as mean ± SEM (N = 4 for Western blot and N = 8 for experiments with inhibitors) and 701 
groups denoted by different letters represent a significant difference at P < 0.05. 702 
 703 
Fig.8    Effects of insulin on MAPK and PI3K/Akt signaling in goldfish hepatocytes.  Hepatocytes 704 
were treated with insulin (10 nM) for the duration as indicated.  After that, cell lysate was prepared 705 
and subjected to Western blot using antibodies for phosphorylated form (“P-”) and total protein (“T-”) 706 
of MEK1/2 and ERK1/2 (A), MKK3/6 and P38 
MAPK (B), and PI3K and Akt (C), respectively.  Parallel 707 
Western blot for β-actin was used as the loading control.  Representative results of Western blot were 708 
shown in the panels on the left while the quantitative data expressed as the ratio of the signal intensity 709 
(registered by densitometric scanning using ImageJ) of the P-form over the T-form of target protein 710 
were presented in the right panels.  Data presented are expressed as mean ± SEM (N = 4) and groups 711 
denoted by different letters represent a significant difference at P < 0.05. 712 
 713 
Fig.9    Blocking MAPK and PI3K/Akt signaling cascades on insulin-induced SPX mRNA expression 714 
in goldfish hepatocytes.  Hepatocytes were incubated with insulin (10 nM) for 48 hr in the presence of 715 
(A) the MEK1/2 inhibitor U0126 (10 µM) or PD98059 (10 µM), (B) the ERK1/2 inhibitor FR180204 (2 716 
µM) or SCH772984 (10 nM), (C) the P38 
MAPK inhibitor PD169316 (10 µM) or SB203580 (10 µM), 717 
(D) the PI3K inhibitor LY294002 (10 µM) or Wortmannin (100 nM), and (E) the Akt inhibitor API-2 718 
(20 µM) or mTOR inhibitor Rapamycin (20 nM)), respectively.  In parallel study, insulin induction 719 
(10 nM) was also tested with co-treatment of MEK1/2 inhibitor PD169316 (10 µM) and PI3K inhibitor 720 
LY294002 (10 µM) simultaneously (F).  After drug treatment, total RNA was isolated and subjected 721 
to real-time PCR for SPX mRNA measurement.  Data presented are expressed as mean ± SEM (N = 722 
8) and groups denoted by different letters represent a significant difference at P < 0.05. 723 
 724 
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Fig.10     Functional role of insulin on SPX gene expression in goldfish brain cells.  (A) Removal of 725 
insulin from culture medium on SPX mRNA expression in primary culture of goldfish brain cells.  In 726 
this study, brain cells were cultured in medium supplemented with B27 (a serum substitute with 4 mg/ 727 
L insulin) or insulin-free B27 (for removing insulin from cell culture) for the duration as indicated.  In 728 
parallel experiments, time course (B) and dose-dependence (C) of insulin treatment on SPX mRNA 729 
expression in goldfish brain cells were also examined in culture medium containing regular B27 (with 730 
insulin).  For time course study, static incubation with insulin (30 nM) was conducted for the duration 731 
as indicated.  For dose-dependence, brain cells were treated for 12 hr with increasing levels of insulin.  732 
To evaluate the receptor specificity for SPX mRNA expression induced by insulin within the CNS of 733 
goldfish, RT-PCR of different isoforms of InsR (InsR1 & InsR2) and IGF1R (IGF1R1 & IGF1R2) was 734 
conducted in the brain as well as brain cells prepared from goldfish (D) using primers specific for the 735 
respective gene targets.  RT-PCR for InsR and IGF1R expressed in muscle was used as the positive 736 
control while parallel PCR for β-actin was used as internal control.  For functional studies, blockade 737 
of InsR and IGF1R on insulin-induced SPX mRNA expression were also tested in goldfish brain cells 738 
(E).  In this case, brain cells were incubated with insulin (30 nM) for 12 hr in the presence/absence of 739 
the InsR inhibitor HNMPA (10 μM) or IGF1R inhibitor PPP (10 μM).  After treatment, total RNA was 740 
isolated and subjected to real-time PCR for SPX mRNA measurement.  Parallel measurement of β-741 
actin mRNA was used as the internal control.  Data presented are expressed as mean ± SEM (N = 8) 742 
and groups denoted by different letters represent a significant difference at P < 0.05. 743 
 744 
Fig.11    Effects of insulin on MAPK and PI3K/Akt signaling in goldfish brain cells.  Brain cells were 745 
challenged with insulin (10 nM) for the duration as indicated.  After that, cell lysate was prepared and 746 
subjected to Western blot using antibodies for phosphorylated form (“P-”) and total protein (“T-”) of 747 
MEK1/2 and ERK1/2 (A), MKK3/6 and P38 
MAPK (B), and PI3K and Akt (C), respectively.  Parallel 748 
Western blot for β-actin was used as the loading control.  Representative results of Western blot were 749 
shown in the panels on the left while the quantitative data expressed as the ratio of the signal intensity 750 
(registered by densitometric scanning using ImageJ) of the P-form over the T-form of target protein 751 
were presented in the right panels.  Data presented are expressed as mean ± SEM (N = 4) and groups 752 
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denoted by different letters represent a significant difference at P < 0.05. 753 
 754 
Fig.12    Blocking MAPK and PI3K/Akt signaling cascade on insulin-induced SPX mRNA expression 755 
in goldfish brain cells.  Primary culture of goldfish brain cells was incubated with insulin (30 nM) for 756 
12 hr with/without (A) the MEK1/2 inhibitor PD98059 (10 µM), ERK1/2 inhibitor FR180204 (2 µM) or 757 
P38 
MAPK inhibitor PD169316 (10 µM)), or (B) PI3K inhibitor LY294002 (10 µM), Akt inhibitor API-2 758 
(20 µM) or mTOR inhibitor Rapamycin (20 nM)), respectively.  After drug treatment, total RNA was 759 
isolated and subjected to real-time PCR for SPX mRNA measurement.  In these experiments, parallel 760 
measurement of β-actin mRNA was used as internal control.  Data presented are expressed as mean ± 761 
SEM (N = 8) and groups denoted by different letters represent a significant difference at P < 0.05. 762 
 763 
Fig.13    Working model for insulin acting as a functional link between feeding and SPX expression in 764 
the liver as well as in the brain of fish model.  In goldfish, food intake can induce insulin expression in 765 
the liver via elevation in blood glucose (probably with parallel rise in insulin signal from the pancreas).  766 
Local production of insulin acts in an autocrine/paracrine manner to up-regulate SPX expression at 767 
the hepatic level mainly via InsR (to a lesser extent by IGF1R) functionally coupled with the MKK3/6/ 768 
P38 
MAPK
 and PI3K/Akt pathways.  SPX produced by the liver enters the systemic circulation and serves 769 
as a peripheral signal acting on the CNS.  Meanwhile, insulin released from the liver (together with 770 
insulin from the pancreas) can elevate insulin level in circulation and exerts a central effect to induce 771 
SPX expression in brain areas involved in feeding control via InsR coupled to MKK3/6 /P38 
MAPK and 772 
PI3K/Akt signaling.  The combined effect of central expression of SPX together with the peripheral 773 
input of SPX can differentially regulate orexigenic and anorexigenic signals expressed in the feeding 774 
circuitry within the CNS and lead to an inhibition on feeding behavior and subsequent suppression of 775 
food intake.  These biological changes are believed to play a role in the initiation of satiation response 776 
after feeding in fish model. 777 
 778 
Supplemental Table (1) 
 
Primer sequences, PCR conditions and QC parameters for real-time PCR of target genes.  
 
Gene name / Genbank accession no   
Sequences of forward & reverse primers 
Real-time PCR condition  
Product size 
& Tm value Denaturing          Annealing          Extension          Detection       Cycle no.      
 
Spexin / JQ894857.1 
Forward:  5’ TAATGTTTCAAGTTCATCCTC 3’ 
Reverse:  5’ AGTGGTTATTTCACAGATCAGTCC 3’ 
   94 ℃                  55 ℃                    72 ℃                80 ℃                ×35  
   30 sec                30 sec                   30 sec               20 sec  
 
156 bp 
(Tm = 86 ℃) 
 
Insulin / KT071542.1 
Forward:  5’ GATGCCCTCTACCTGGTCTG 3’ 
Reverse:  5’ TCCTTATCAGCTCTGCGTGA 3’ 
   94 ℃                  64 ℃                    72 ℃                84 ℃                ×35 
   30 sec                30 sec                   30 sec               20 sec  
 
157 bp 
(Tm = 88 ℃) 
 
IGF-I / GU583648.1 
Forward:  5’ TTCAAGTGTACCATGCGCTG 3’ 
Reverse:  5’ ACCGTCTTGAATTAGGCCCA 3’ 
   94 ℃                  62 ℃                    72 ℃                 88 ℃                ×35 
   30 sec                30 sec                   30 sec               20 sec 
 
201 bp 
(Tm = 93 ℃) 
 
IGF-II / FJ410929.1 
Forward:  5’ AGACCCTTTGCGGTGGAGA 3’ 
Reverse:  5’ GGAAACATCTCGCTCGGACT 3’ 
   94 ℃                  62 ℃                    72 ℃                 84 ℃                ×35 
   30 sec                30 sec                   30 sec               20 sec 
 
200 bp 
(Tm = 90 ℃) 
 
18S RNA / HQ615531.1  
Forward:  5’AGCAACTTTAGTATACGCTATTGGAG 3’ 
Reverse:  5’ CCTGAGAAACGGCTACCACATCC 3’ 
   94 ℃                  56 ℃                    72 ℃                 87 ℃                 ×30 
   30 sec                30 sec                   30 sec               20 sec 
 
285 bp 
(Tm = 91 ℃) 
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 Supplemental Table (2) 
 
Primer sequences, PCR conditions and QC parameters for RT-PCR of target genes.  
 
 
Gene name / Genbank accession no   
Sequences of forward & reverse primers 
PCR condition Product 
size Denaturing       Annealing        Extension         Cycle no. 
Insulin / KT071542.1 
Forward:  5’ GATGCCCTCTACCTGGTCTG 3’ 
Reverse:  5’ TCCTTATCAGCTCTGCGTGA 3’ 
   94 ℃                 64 ℃                72 ℃               ×35 
   30 sec               30 sec               40 sec  
157 bp 
InsR1 / AF218355.1 
Forward:  5’ AGGAAGAAACAAACCGAAGGACC 3’  
Reverse:  5’ ACACCGAGCAAGCGAAGCAC 3’ 
   94 ℃                 62 ℃               72 ℃                ×35  
   30 sec               30 sec               40 sec 
323 bp 
InsR2 / AF321225.1 
Forward:  5’ GAAGAAAGAGGCGGAGGAGAC 3’ 
Reverse:  5’ CAGATTGGAGATGACCGTTGACT 3’ 
   94 ℃                59 ℃                72 ℃                ×35  
   30 sec               30 sec              40 sec 
252 bp 
IGF1R1 / AF216772.2 
Forward:  5’ ACCAGAGCGGCAGATAGAGC 3’ 
Reverse:  5’ GGATGATGATGTAGGACAGGTAGTG 3’ 
   94 ℃                59 ℃                72 ℃                ×35 
   30 sec               30 sec              40 sec 
352 bp 
IGF1R2 / AF216773.2 
Forward:  5’ CATCGCAAAGGGCGTCGTCA 3’ 
Reverse:  5’ TGCCATCCCGTCCGCAATCT 3’ 
   94 ℃                67 ℃                72 ℃                ×35 
   30 sec               30 sec              40 sec 
325 bp 
β-actin / AB039726.2 
Forward:  5’ CTGGTATTCGTGATGGACTCT 3’ 
Reverse:  5’ AGCTCATAGCTCTTCTCCAG 3’ 
   94 ℃                56 ℃                72 ℃                ×30 
   30 sec               30 sec              40 sec  
285 bp 
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Peptide/protein target Antigen sequence (if known) Name of Antibody / RRID
Manufacturer, catalog #, and/or name of individual providing 
the antibody
Species raised in; monoclonal or 
polyclonal
Dilution used
Phospho-MEK1/2 A synthetic phosphopeptide (KLP-coupled) corresponding to residues around Ser217/221 of human MEK1/2. Phospho-MEK1/2 (Ser217/221) mAb / AB_2138017 Cell Signaling Technology, Inc., catalog #9154 monoclonal IgG in Rabbit 1:1,000 for WB
Total MEK1/2 A synthetic peptide (KLH coupled) covering the conserved region of human, rat and mouse MEK1/2. MEK1/2 Antibody (for total MEK1/2) / AB_823567 Cell Signaling Technology, Inc., catalog #9122 polyclonal in Rabbit 1:1,000 for WB
Phospho-ERK1/2 A synthetic peptide (KLH coupled) with HTGFLTpEYpVAT sequence corresponding to the phosphorylated form of ERK-activation loop. Diphosphorylated ERK1/2 mAb / AB_477245 Sigma-Aldrich Co. , catalog #M8159 monoclonal IgG in Mouse 1:5,000 for WB
Total ERK-1/2 A synthetic peptide (KLH coupled) with  RRITVEEALAHPYLEQ YYDPTDE sequence derived from subdomain-XI of human ERK1/2. ERK1/2 Antibody (for total ERK1/2) / AB_477216 Sigma-Aldrich Co. , catalog #M5670 polyclonal in Rabbit 1:5,000 for WB
Phospho-MKK3/6
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues around 
Ser189/207 of human MKK3
Phospho-MKK3 (Ser189)/MKK6 (Ser 207) Antibody / AB_2140799 Cell Signaling Technology, Inc., catalog #9231 polyclonal in Rabbit 1:2,000 for WB
Total MKK3
Synthetic peptide directed towards the C terminal of human MAP2K3  
(EEPSPQLPADRFSPEFVDFTAQCLRKNPAERMSYLELMEHPFFTLHKTKK)
MAP2K3 (mitogen-activated protein kinase kinase 3) Antibody 
(against  C terminal of MAP2K3)/ AB_2046667
AVIVA SYSTEMS BIOLOGY, catalog #ARP42065_P050 polyclonal in Rabbit 1:2,000 for WB
Phospho-p38 MAPK A synthetic phosphopeptide corresponding to residues around Thr180/Tyr182 of human p38 MAPK. Phospho-p38 MAPK (Thr180/Tyr182) Antibody / AB_331641 Cell Signaling Technology, Inc., catalog #9211 polyclonal in Rabbit 1:1,000 for WB
Total p38 MAPK A synthetic peptide corresponding to the sequence of human p38 MAPK. p38 MAPK Antibody /AB_330713 Cell Signaling Technology, Inc., catalog #9212 polyclonal in Rabbit 1:1,000 for WB
Phospho-PI3K
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide  corresponding to residues surrounding 
Tyr458 of mouse  p85
Phospho-PI3 Kinase p85 (Tyr458)/p55 (Tyr199) Antibody / AB_659940 Cell Signaling Technology, Inc., catalog #4228 polyclonal in Rabbit 1:2,000 for WB
Total PI3K Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of human PI3K p85. PI3 Kinase p85 (19H8) Rabbit mAb / AB_10695255 Cell Signaling Technology, Inc., catalog #4257 monoclonal IgG in Rabbit 1:2,000 for WB
Phospho-Akt A synthetic phosphopeptide (KLH-coupled) corresponding to residues surrounding Ser473 of mouse Akt. Phospho-Akt (Ser473) Antibody / AB_329825 Cell Signaling Technology, Inc., catalog #9271 polyclonal in Rabbit 1:5,000 for WB
Total Akt A synthetic peptide (KLH-coupled) derived from the carboxy-terminal sequence of mouse Akt. Akt Antibody (for total Akt) / AB_329827 Cell Signaling Technology, Inc., catalog #9272 polyclonal in Rabbit 1:1,500 for WB
Phospho-InsR Synthetic phosphopeptide derived from human Insulin Receptor around the phosphorylation site of tyrosine 1361 (I-P-YP-T-H). Insulin Receptor (phospho Y1361) antibody / AB_943587 Abcam, catalog #ab60946 polyclonal in Rabbit 1:2,000 for WB
Antibody Table
